Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Endothelin B-receptors and sympathetic activation: impact on ventricular arrhythmogenesis during acute myocardial infarction.

Kolettis TM, Oikonomidis DL, Baibaki ME, Barka E, Kontonika M, Tsalikakis DG, Papalois A, Kyriakides ZS.

Life Sci. 2014 Nov 24;118(2):281-7. doi: 10.1016/j.lfs.2014.01.069. Epub 2014 Feb 3.

2.

Endothelin-B receptors and ventricular arrhythmogenesis in the rat model of acute myocardial infarction.

Oikonomidis DL, Tsalikakis DG, Baltogiannis GG, Tzallas AT, Xourgia X, Agelaki MG, Megalou AJ, Fotopoulos A, Papalois A, Kyriakides ZS, Kolettis TM.

Basic Res Cardiol. 2010 Mar;105(2):235-45. doi: 10.1007/s00395-009-0066-7. Epub 2009 Oct 17.

PMID:
19838761
3.

Effects of dual endothelin receptor blockade on sympathetic activation and arrhythmogenesis during acute myocardial infarction in rats.

Kolettis TM, Baltogiannis GG, Tsalikakis DG, Tzallas AT, Agelaki MG, Fotopoulos A, Fotiadis DI, Kyriakides ZS.

Eur J Pharmacol. 2008 Feb 2;580(1-2):241-9. Epub 2007 Nov 13.

PMID:
18048027
4.

Central Sympathetic Activation and Arrhythmogenesis during Acute Myocardial Infarction: Modulating Effects of Endothelin-B Receptors.

Kolettis TM, Kontonika M, Barka E, Daskalopoulos EP, Baltogiannis GG, Tourmousoglou C, Papalois A, Kyriakides ZS.

Front Cardiovasc Med. 2015 Feb 23;2:6. doi: 10.3389/fcvm.2015.00006. eCollection 2015.

5.

Ventricular tachyarrhythmias during acute myocardial infarction: the role of endothelin-1.

Kolettis TM.

Life Sci. 2014 Nov 24;118(2):136-40. doi: 10.1016/j.lfs.2014.01.060. Epub 2014 Jan 28. Review.

6.

Do endothelin receptor antagonists have an antiarrhythmic potential during acute myocardial infarction? Evidence from experimental studies.

Oikonomidis DL, Baltogiannis GG, Kolettis TM.

J Interv Card Electrophysiol. 2010 Sep;28(3):157-65. doi: 10.1007/s10840-010-9493-5. Epub 2010 Jun 8. Review.

PMID:
20532602
7.

Autonomic responses during acute myocardial infarction in the rat model: implications for arrhythmogenesis.

Kolettis TM, Kontonika M, Lekkas P, Vlahos AP, Baltogiannis GG, Gatzoulis KA, Chrousos GP.

J Basic Clin Physiol Pharmacol. 2018 Jul 26;29(4):339-345. doi: 10.1515/jbcpp-2017-0202.

PMID:
29634485
8.

Local conduction during acute myocardial infarction in rats: Interplay between central sympathetic activation and endothelin.

Kolettis TM, Kontonika M, La Rocca V, Vlahos AP, Baltogiannis GG, Kyriakides ZS.

J Arrhythm. 2017 Apr;33(2):144-146. doi: 10.1016/j.joa.2016.07.010. Epub 2016 Aug 31.

9.

Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.

Lee TM, Chen CC, Lin MS, Chang NC.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1871-9. doi: 10.1152/ajpheart.01129.2007. Epub 2008 Feb 15.

10.

Effects of ghrelin on Cx43 regulation and electrical remodeling after myocardial infarction in rats.

Yuan MJ, Huang H, Tang YH, Wu G, Gu YW, Chen YJ, Huang CX.

Peptides. 2011 Nov;32(11):2357-61. doi: 10.1016/j.peptides.2011.10.004. Epub 2011 Oct 8.

PMID:
22008733
11.

Arrhythmogenesis after acute myocardial necrosis with and without preceding ischemia in rats.

Kolettis TM, Kontonika M, Valenti MC, Vilaeti AD, Baltogiannis GG, Papalois A, Kyriakides ZS.

J Basic Clin Physiol Pharmacol. 2014 May 1;25(2):143-53. doi: 10.1515/jbcpp-2013-0117.

PMID:
24114909
12.

Effects of central sympathetic activation on repolarization-dispersion during short-term myocardial ischemia in anesthetized rats.

Kolettis TM, La Rocca V, Psychalakis N, Karampela E, Kontonika M, Tourmousoglou C, Baltogiannis GG, Papalois A, Kyriakides ZS.

Life Sci. 2016 Jan 1;144:170-7. doi: 10.1016/j.lfs.2015.12.019. Epub 2015 Dec 8.

PMID:
26679103
13.

Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model.

Van Kerckhoven R, van Veen TA, Boomsma F, Saxena PR, Schoemaker RG.

Eur J Pharmacol. 2000 May 26;397(1):113-20.

PMID:
10844105
14.

Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction.

Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H, Kangawa K.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H426-32. Epub 2007 Nov 16.

15.

Inhibition of Notch signaling pathway attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats post-myocardial infarction.

Yin J, Hu H, Li X, Xue M, Cheng W, Wang Y, Xuan Y, Li X, Yang N, Shi Y, Yan S.

Am J Physiol Cell Physiol. 2016 Jan 1;310(1):C41-53. doi: 10.1152/ajpcell.00163.2015. Epub 2015 Oct 21.

17.

Sympathetic modulation of electrical activation in normal and infarcted myocardium: implications for arrhythmogenesis.

Ajijola OA, Lux RL, Khahera A, Kwon O, Aliotta E, Ennis DB, Fishbein MC, Ardell JL, Shivkumar K.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H608-H621. doi: 10.1152/ajpheart.00575.2016. Epub 2017 Jan 13.

18.

Ventricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels.

Gui L, Bao Z, Jia Y, Qin X, Cheng ZJ, Zhu J, Chen QH.

Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H118-30. doi: 10.1152/ajpheart.00820.2011. Epub 2012 Oct 19.

19.

Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure.

Du XJ, Cox HS, Dart AM, Esler MD.

Cardiovasc Res. 1999 Sep;43(4):919-29.

PMID:
10615419
20.

Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.

Schömig A, Richardt G, Kurz T.

Herz. 1995 Jun;20(3):169-86. Review.

PMID:
7635399

Supplemental Content

Support Center